-
Data insight into the status and trends of IVD products in my country
Time of Update: 2022-04-27
In terms of market size, Figure 1: The market share of IVD in China Data source: China Industry Information Network In terms of products, as of February 28, 2022, there were 31,177 valid registration certificates for Type II and Type III in vitro diagnostic reagents in China, of which immunodiagnosis, biochemical diagnosis and molecular diagnostic products accounted for 38%, 47% and 3% respectively.
-
How to choose a biological safety cabinet?
Time of Update: 2022-04-27
1: Concepts related to biosafety cabinets The concept of biosafety has a narrow sense and a broad sense. The narrow sense biosafety refers to the prevention of the negative effects caused by the dev
-
Features of Heat Reflux Extraction Unit
Time of Update: 2022-04-27
There are many kinds of traditional Chinese medicine extraction equipment for heat reflux extraction unit, each with its own merits .
-
Safety operation rules for automatic sampling tube filling machine
Time of Update: 2022-04-27
Today, Shanghai Shenggang will sort out the safety operation rules of the automatic sampling tube filling machine for you .
Automatic sampling tube filling machine Equipment cleaning requirements: 1.
-
U.S. passes 'competition' bill aimed at cracking down on APIs, drugs and medical devices from China
Time of Update: 2022-04-27
According to the latest USP data, the total number of manufacturing facilities capable of producing more than 10 US-approved API products in India, Europe and China is 183, 83 and 35, respectively .
-
Application characteristics of tilting reactor
Time of Update: 2022-04-27
The tilting reaction pot is composed of pot body, bracket, worm gear, worm and other components.
The tilting reaction pot is widely used in the processing of various foods, and can also be used in large restaurants or canteens for soup, cooking, stew, porridge, etc.
-
Double mutated again?
Time of Update: 2022-04-27
The UK Health and Safety Agency (UKHSA) has confirmed that a recombinant variant of the Omicron sub-strain binding, currently named XE, has been found in the UK .
-
More than 1.2 million CAR-T needles or price cuts?
Time of Update: 2022-04-27
Judging from the number of product approvals, domestic tumor immunotherapy closely follows the pace of international development and has become the second largest market after the United States, and there are still more than 500 cell therapy projects in the clinical research stage .
-
Focus: The annual reports of domestic pharmaceutical companies have been released one after another. How is the commercialization of blockbuster products?
Time of Update: 2022-04-27
In 2021, Vidicitumab for injection will achieve sales of 84 million yuan , covering 374 hospitals and about 2,139 patients in 105 prefecture-level cities in 29 provincial administrative units across the country .
-
In the PD1+ era, how many combined immunization regimens have been approved?
Time of Update: 2022-04-27
⑧ Sintilimab combined with pemetrexed and platinum in the treatment of advanced and untreated EGFR/ALK-negative non-squamous non-small cell lung cancer⑧ Sintilimab combined with pemetrexed and platinum in the treatment of advanced and untreated EGFR/ALK-negative non-squamous non-small cell lung cancer ORIENT11 study: Sintilimab combined with pemetrexed, platinum versus chemotherapy alone in the treatment of advanced naive EGFR/ALK-negative non-squamous non-small cell lung cancer, the primary endpoint PFS was 8.
-
The Health and Health Commission first mentioned "off-indication use", is the commercialization of tumor drugs ready for a turnaround?
Time of Update: 2022-04-27
This official release of the use of off-label clinical indications not only reduces the legal risks of doctors in the use of some special drugs, but also, to a certain extent, is a disguised “acceleration of approval” for innovative drugs when looking at the pharmaceutical industry .
-
The new crown drug market exceeds 100 billion US dollars!
Time of Update: 2022-04-27
In an environment where anti-epidemic has become normalized, vaccines, neutralizing antibodies, and small-molecule "special drugs" for the new crown developed by various pharmaceutical companies are also emerging one after another .
-
Daily cleaning and maintenance of automatic oral liquid filling machine
Time of Update: 2022-04-27
The daily cleaning and maintenance of the automatic oral liquid filling machine is very useful for the service life of the automatic filling machine, so it is necessary for the equipment personnel to carry out daily maintenance of the equipment every day .
-
The General Department of the State Food and Drug Administration publicly solicits opinions on the "Check Points for Drug Marketing Authorization Holders (Draft for Comment)"
Time of Update: 2022-04-27
cn before April 30, 2022, and the email subject should be marked "Holder's Check Point Feedback" .
Attachment: Check Points for Drug Marketing Authorization Holders (Draft for Comment) General Department of the State Food and Drug Administration March 28, 2022 Attachment.
-
Precautions for emptying and adding liquid of the integrated medical high and low temperature cooling machine
Time of Update: 2022-04-27
When adding liquid to the integrated medical high and low temperature cooling machine, pay attention to open the cover counterclockwise, insert the funnel to inject the heat transfer medium, so that the liquid fills the expansion liquid surface; 6.
-
FDA grants priority review to futibatinib, FGFR inhibitor tripartite situation may be broken
Time of Update: 2022-04-27
In April 2021, futibatinib was granted Breakthrough Drug Designation by the FDA for the treatment of patients with previously treated locally advanced or metastatic cholangiocarcinoma harboring FGFR2 gene rearrangements .
-
412 million, 1.621 billion... Will domestic PD-1s sell well in 2021?
Time of Update: 2022-04-27
It is worth mentioning that with the inclusion of 3 new indications, including first-line treatment of non-squamous non-small cell lung cancer (NSCLC), into the new version of the National Medical Insurance List, BeiGene surpassed Hengrui Medicine, Junshi Bio, and Innovent Bio.
-
Two Gene Editing Companies Join Forces: Myeloid and Prime Sign Exclusive Partnership Agreement to Accelerate Development of Next-Generation RNA-Based Gene Editing Technology
Time of Update: 2022-04-27
If successful, the technology could be used with Prime Editing to transform and simplify the delivery of in vitro and in vivo cell therapies to treat human diseases .
With the advancement of gene editing technology and the development of vectors, the market size of gene and cell therapy continues to expand .
-
Clinical CRO "Clash of Kings"!
Time of Update: 2022-04-27
It was after this stage that Tigermed and WuXi AppTec, two listed companies rooted in clinical CROs, ushered in a high performance growth that they had never had before.
-
Clear the cloud and see the sun, and comprehensively analyze the performance of Sino Biopharmaceutical's main products in 2021
Time of Update: 2022-04-27
Figure 5: The number of drugs that passed the consistency evaluation of Chia Tai Tianqing (unit: piece) Data source: Zhongkang CHIS system Changes in the market share of products after winning the bid need to be differentiated between in-hospital and out-of-hospital .